Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jul;41(7):1431-9.
doi: 10.1161/STROKEAHA.110.583815. Epub 2010 Jun 3.

The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset

Affiliations
Comparative Study

The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset

Jeffrey L Saver et al. Stroke. 2010 Jul.

Abstract

Background and purpose: The benefit of intravenous thrombolytic therapy in acute brain ischemia is strongly time dependent.

Methods: The Get With the Guidelines-Stroke database was analyzed to characterize ischemic stroke patients arriving at hospital Emergency Departments within 60 minutes of the last known well time from April 1, 2003, to December 30, 2007.

Results: During the 4.75-year study period, among 253 148 ischemic stroke patients arriving directly by ambulance or private vehicle at 905 hospital Emergency Departments, 106 924 (42.2%) had documented, exact last known well times. Onset to door time was <or=60 minutes in 30 220 (28.3%), 61 to 180 minutes in 33 858 (31.7%), and >180 minutes in 42 846 (40.1%). Features most strongly distinguishing the patients arriving at <or=60, 61 to 180, and >180 minutes were greater stroke severity (median National Institutes of Health Stroke Scale score, 8.0 vs 6.0 vs 4.0, P<0.0001) and more frequent arrival by ambulance (79.0%. vs 72.2% vs 55.0%, P<0.0001). Compared with patients arriving at 61 to 180 minute, "golden hour" patients received intravenous thrombolytic therapy more frequently (27.1% vs 12.9%; odds ratio=2.51; 95% CI, 2.41-2.61; P<0.0001), but door-to-needle time was longer (mean, 90.6 vs 76.7 minutes, P<0.0001). A door-to-needle time of <or=60 minutes was achieved in 18.3% of golden hour patients.

Conclusions: At Get With the Guidelines-Stroke hospital Emergency Departments, more than one quarter of patients with documented onset time and at least one eighth of all ischemic stroke patients arrived within 1 hour of onset, where they received thrombolytic therapy more frequently but more slowly than late arrivers. These findings support public health initiates to increase early presentation and shorten door-to-needle times in patients arriving within the golden hour.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest/Disclosures: Dr Saver serves as a member of the Get With the Guidelines Science Subcommittee, as a scientific consultant regarding trial design and conduct to CoAxia, Concentric Medical, Talecris, and Ev3 (all modest); received lecture honoraria from Ferrer and Boehringer Ingelheim (modest); was an unpaid investigator in a multicenter prevention trial sponsored by Boehringer Ingelheim; has declined consulting/honoraria monies from Genentech since 2002; is an employee of the University of California, which holds a patent on retriever devices for stroke.

Dr. Smith receives research support from the NIH (NINDS R01 NS062028) the Canadian Stroke Network, and the Hotchkiss Brain Institute and Canadian Institutes for Health Research, and salary support from the Canadian Institutes for Health Research.

Dr. Fonarow receives research support from the National Institutes of Health (significant), serves as a consultant to Pfizer, Merck, Schering Plough, Bristol Myers Squibb, and Sanofi-Aventis (all modest); receives speaker honoraria from Pfizer, Merck, Schering Plough, Bristol Myers Squibb, and Sanofi-Aventis (all significant); and is an employee of the University of California, which holds a patent on retriever devices for stroke.

Dr. Reeves receives salary support from the Michigan Stroke Registry

Dr. Zhao is a member of the Duke Clinical Research Institute which serves as the AHA GWTG data coordinating center.

Dr. Olson is a member of the Duke Clinical Research Institute which serves as the AHA GWTG data coordinating center.

Dr. Schwamm serves as a consultant to the Research Triangle Institute, CryoCath, and to the Massachusetts Department of Public Health.

Figures

Figure 1
Figure 1
Relation of onset to door versus door to needle times among all IV TPA within 3 hours treated ischemic stroke patients (n=11883). Mean OTD time was 56.3 (± 28.5) and DTN time 84.1 (± 29.0). The correlation coefficient was -0.30.
Figure 2
Figure 2
Distribution of door to needle times among patients arriving in ED within first 60 minutes after onset. Bracket shows proportion treated within DTN ≤ 60 minutes stretch target.

Similar articles

Cited by

References

    1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. - PubMed
    1. Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke. 2009;40:2079–2084. - PMC - PubMed
    1. Saver JL. Time is brain--quantified. Stroke. 2006;37:263–266. - PubMed
    1. Marler JR, Winters Jones P, Emr M. The National Institute of Neurological Disorders and Stroke: Proceedings of National Symposium on Rapid Identification and Treatment of Acute Stroke; Bethesda, MD. 1997.
    1. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–282. - PubMed

Publication types

Substances